Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event
    Summit & Event ：
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
    Learn More>
    Wealth & Capital Management
    Insurance & Finance
    Healthcare & Pharma
    Retail & FMCG
    Travel & Transportation
  • Shine Speaker Bureau
    Shine Speaker Bureau：
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
    Learn More>
    The Leader Networks
    Advisor
    Think-Tank
  • Shine Advisor
    Shine Advisor：
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
    Learn More>
    Briefing
    Consensus
    Customized Research
  • Shine Event Service
    Shine Event Service：
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
    Learn More>
Guest Information
LI Gongshu
LI Gongshu
发布时间: 2018 - 01 - 12
点击次数: 0
Positions： Senior Vice President
Company： Fountain Medical (TIANJIN) Co., Ltd.
个人简介：
Gongshu Li is Senior Vice President of Fountain Medical Development LTD. Great China, Chief Medical Officer of Chinese and Botanica Medicine.She served as the senior reviewer and deputy office director of the office of TCM clinical evaluation in the Center for Drug Evaluation( CDE) of the China Food and Drug Administration( CFDA) for 12 years. She was the director of the institutions office of Guang 'anmen hospital of the China Academy of Chinese Medicine Sciences for 3 years. She graduated from China Academy of Chinese Medicine Sciences. Doctor of medicine in oncology. She worked as an oncologist for ten years.
查看详情>>
Angela YAN
Angela YAN
发布时间: 2018 - 01 - 12
点击次数: 0
Positions： Senior Director - Science & Regulatory
Company： RDPAC
个人简介：
Ms. Angela Yan (闫慧) has joined RDPAC as Senior Director- Science & Regulatory Committee since October 14, 2013 and is responsible for Science & Regulatory Committee including R&D Working Group (Clinical Operation FG, Non-clinical FG, Medical Affairs FG and PV FG) and Regulatory Working Group (CMC FG, Biotherapeutic FG, Quality FG and Regulatory Intelligence FG). She is mainly responsible for interaction between government regulatory departments and RDPAC member companies in terms of R&D and regulatory affairs, as well as keeping good cooperation with international sister associations (e.g. PhRMA/ EFPIA/ BIO/ JPMA). Angela Yan has rich experience in the field of Regulatory Science in China with MNCs. Before joining RDPAC, Angela held a couple of critical regulatory leadership positions. Over the last 20 years, she worked as China Head of Regulatory Affairs in BMS for 3 years, GSK for 11 years and Schering-Plough for near 2 years respectively. Her last job was the Head of Regional Regulatory Affair for Asia (Oncology ) in Takeda Shanghai Development Center for one year.  Angela was authorized with EMBA degree during 2000~2002 in China-Europe International Bossiness School. She has medical background, graduated from Capital University of Medicine and worked in Beijing Tiantan Hospital as Neurologist for 3 years.
查看详情>>
Helen MAO
Helen MAO
发布时间: 2018 - 01 - 12
点击次数: 0
Positions： Senior Vice President / Board of Director
Company： CanSino Biologics Inc./ CBA -The Chinese Biopharmaceutical Association-USA
个人简介：
Dr. Helen H. Mao is a senior professional with over 25 years experiences in global pharmaceutical industries, specialized in new product development, technology transfer, quality systems management, regulatory affairs and business management. Dr. Mao has extensive experiences in new drug development and commercialization in US, Canada and Asia, successfully developed and launched multiple new products including blockbuster drugs and biologic products.Dr. Mao obtained her Master and Ph.D. degrees from Chinese Academy of Sciences; and completed post-doctoral research at Industrial Biotechnology Center，University of Waterloo. She also holds a MBA degree from Villanova University in Pennsylvania. She is a registered Professional Engineer (PEng). Previously Dr. Mao held various positions with increased responsibilities at US multinational companies, including of Director of Quality at Pfizer (Wyeth) and Director of Quality at Endo Pharmaceuticals. Dr. Mao is Co-founder and Senior Vice President of CanSino Biologics Inc. which specializes in the development and commercialization of innovative vaccine products. In Oct.2017 CanSino Biologics successfully developed an Ebola Virus Disease Vaccine (EBOV), and obtained new drug approval from CFDA. Dr. Mao is Adjourn Professor of Tianjin University of Sciences and Technology and Nankai University.  Dr. Mao is currently a Board of Director with Chinese Biopharmaceutical Association (CBA-US) and a member of BayHelix Association.
查看详情>>
JOHN WINEBARGER
JOHN WINEBARGER
发布时间: 2018 - 01 - 10
点击次数: 0
Positions： CEO
Company： Japanese pharmaceutical companies
个人简介：
Mr. John Winebarger has lived and worked in Japan since 1984. He has focused his career on assisting Japanese pharmaceutical companies in developing US/EU regulatory and development strategies as well as supporting and advising western companies through innovative approaches to accelerating and integrating Japan and Asia into global drug development. Mr. Winebarger worked for Otsuka Pharmaceutical Co., Ltd. in Japan and the US from 1988 to 1996, where he helped establish and manage Otsuka’s expanding global clinical development operations. In 1997, Mr. Winebarger joined PPD and initially served as Executive Director of Pan-Asian Business Development. In this position he was instrumental in building PPD’s product development business which focused on Japanese, Korean and Taiwanese companies seeking entry into the US market. Mr. Winebarger also drove the formation of PPD’s Asian presence, establishing PPD Japan as well as PPD Thailand. In 2004, Mr. Winebarger left PPD to establish IDA.  To date IDA has worked with 50+ companies to enable accelerated drug development strategies for Japan and Asia, including Regulatory Consultations, Orphan Drug and SAKIGAKE Designations and full-service clinical trial implementation as a Clinical Trial In Country Caretaker ("CT-ICC").
查看详情>>